Medtronic plc. vs Pfizer, Inc. — Stock Comparison

Medtronic plc. (MDT) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.

Q·Score Winner
Medtronic plc.
MDT7.1/10vs 6.2/10

Medtronic plc. scores ahead of Pfizer, Inc. on Q·Score (7.1 vs 6.2 out of 10), led by Growth (7.9 vs 5.1) and Sentiment (6.7 vs 5.3). Analyst consensus targets imply greater upside for MDT (+22.2%) than for PFE (+11.4%).

Price Performance

Normalised to 100 at period start — shows relative performance.

Loading…
MDTPFE

Q·Score Breakdown

7.1
Bullish
Overall
6.2
Neutral
6.4
Quality
6.4
7
Health
7
7.9
Growth
5.1
7.7
Valuation
7
6.7
Sentiment
5.3
MDT

Earnings growing 17% year-over-year on 10% revenue growth.

PFE

Consistently beats earnings estimates (4/4 quarters).

earnings contracting 10% year-over-year.

Analyst Consensus

Bullish
+22.2%
Target $98.00
26 analysts
Neutral
+11.4%
Target $29.19
27 analysts

Fundamentals

MDT
PFE
21.5×
Trailing P/E
20.0×
12.5×
Forward P/E
9.3×
13.20%
Profit Margin
11.83%
65.38%
Gross Margin
74.80%
9.93%
ROE
8.31%
9.90%
Revenue Growth
5.40%
17.10%
Earnings Growth
-10.10%
0.60
Beta
0.29
3.59%
Dividend Yield
6.56%
$103.0B
Market Cap
$149.4B
52-Week Range
MDT
$7321% of range$106
PFE
$2355% of range$29

Frequently Asked Questions

MDT vs PFE: which stock scores better overall?

Based on Q·Score, Medtronic plc. (MDT) scores 7.1/10 versus Pfizer, Inc. (PFE) at 6.2/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.

Which has better revenue growth: MDT or PFE?

Medtronic plc. (MDT) scores higher on Growth (7.9/10 vs 5.1/10). Medtronic plc. reports revenue growth (9.9% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Is MDT or PFE more attractively valued?

Medtronic plc. (MDT) scores higher on Valuation (7.7/10 vs 7/10). MDT trades at 12.5× P/E versus PFE at 9.3×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

What do analysts say about MDT vs PFE?

There are 26 analysts covering MDT with a consensus price target of $98.00, and 27 analysts covering PFE with a consensus target of $29.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Which is more profitable: MDT or PFE?

Medtronic plc. (MDT) scores higher on Quality (6.4/10 vs 6.4/10). Net profit margin: MDT at 13.2%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Which has stronger financial health: MDT or PFE?

Medtronic plc. (MDT) scores higher on Financial Health (7/10 vs 7/10). Market beta: MDT at 0.60, PFE at 0.29. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

What are the market caps of MDT and PFE?

Medtronic plc. (MDT) has a market capitalisation of $103.0B, while Pfizer, Inc. (PFE) has a market cap of $149.4B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Do MDT or PFE pay dividends?

MDT pays a dividend yield of 3.59%, while PFE pays a dividend yield of 6.56%. Dividend yields fluctuate with share price and company payout decisions.

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →

Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026